Related Experiment Video
Updated: Jul 16, 2026
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Retroperitoneal lymph node dissection in testicular cancer
Niels-Erik B Jacobsen1, Richard S Foster, John P Donohue
1Department of Urology, Indiana University, Indiana Cancer Pavilion, 535 N Barnhill Drive, Suite 420, Indianapolis, IN 46202, USA.
Abstract:
With long-term survival in excess of 90% across all stages, testicular cancer has come to represent the model for successful multidisciplinary cancer care. Retroperitoneal lymph node dissection (RPLND) remains an integral component of testis cancer management strategies for both early- and advanced-stage disease. Commensurate with improvements made in clinical staging and in our understanding of the natural history of testis cancer, lymphatic spread, and neuroanatomy, considerable modifications in the technique and template of RPLND have taken place. The morbidity of primary RPLND and postchemotherapy RPLND is low when performed by experienced surgeons. This article reviews the evolution, role, and technique of RPLND in contemporary practice.
